House and Senate Opioid Packages Comparison

By Emma Zimmerman

The opioid epidemic has driven significant legislation this session.  To help our readers track the pending opioid legislation, ML Strategies has created a chart to analyze various provisions of House and Senate bills and their overlap.  The chart compares the provisions of HR 6 – SUPPORT for Patients and Communities Act, passed by the House on June 22, 2018, and the Senate’s combined package of opioid legislation that we previously analyzed here.  The Senate is aiming to pass its opioid package after Labor Day.  If the Senate package passes, the House and Senate need to reconcile differences between the two opioid bills.  As the chart indicates, there are significant differences between the packages, so many issues will need to be resolved before this legislation lands on the President’s desk.

*Madeleine Giaquinto and Olivia Graham also contributed to this post.

Subscribe To Viewpoints

Published

    • Viewpoint Topics

  • Health Care

    • Related Practices

  • Medicare, Medicaid & Commercial Coverage & Reimbursement

    • Related Industries

  • Digital Health

    • Author

    Emma Zimmerman

    Emma Zimmerman is an Assistant at ML Strategies, supporting government relations efforts relating to Medicare, Medicaid, Disproportionate Share Hospital (DSH) payments, and the 340B drug discount program.